Aqsitania will be present at the Mobile World Congress 2023 in Barcelona, from February 27th to March 2nd, within the 4YFN start-up event hall 8.1. We present our innovation for the care management of chronic pulmonary diseases: detection, diagnosis support, tele-monitoring, patient empowerment. A new way to assess pulmonary function, simple and effective, no exertion, anyone can do it by himself : “Show me how you breath, I’ll tell how you are”. Visit us at our booth 8.1A50, French pavilion, French Tech, BusinessFrance, CCI-Aquitaine #digitalhealth #TeamNAqui
Category Archives: Event
Aqsitania Ventilometry at the international ERS conference (European Respiratory Society), Barcelona, September 2022
Three important results were presented by Aqsitania, in collaboration with prominent clinicians, showing the capacity of our pulmonary function assessment method for diagnosis support: “just show me how you breathe”. A unique and truly disruptive innovation that opens up a large perspective in detection, follow-up and monitoring of chronic pulmonary diseases.
« Personal respiratory profiles assessed at rest ventilometry distinguished asthmatic from COPD patients » P. Hanusse 1 , P. Laveneziana 3 , F. Beaufils 2 , J. Joie 1 , C. Straus 3 , P. O. Girodet 2 , T. Similowski 3 , P. Berger 2 ;
« Personal respiratory profiles assessed at rest ventilometry predict phenotypes of asthmatic patients » P. Hanusse 1 , F. Beaufils 2 , J. Joie 1 , P. Laveneziana 3 , C. Straus 3 , T. Similowski 3 , P. O. Girodet 2 , C. Pison 4 , P. Berger 2;
« Respiratory profiles assessed by rest ventilometry predict response to bronchodilator of COPD patients » ; P. Hanusse 1 , P. Laveneziana 3 , F. Beaufils 2 , J. Joie 1 , C. Strauss 3 , P. O. Girodet 2 , P. Berger 2 , T. Similowski 3
1 AqsitaniaSAS – Pessac (France), 2 Sorbonne University – Paris (France), 3 Bordeaux University -Pessac (France)
Aqsitania is part of the WeStart program
Aqsitania is part of the WeStart program organized by the pharmaceutical laboratory Chiesi and the technological company IBM, intended to promote and industrialize its innovation for the management of chronical respiratory diseases. We talk about it in the specialized press…
- TIC Pharma : Chiesi et IBM s’allient pour améliorer l’éducation thérapeutique et l’observance des patients
- mind Health : Chiesi démarre un programme d’accompagnement de start-up avec IBM.
See you soon!